The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 30, 2018

Filed:

Feb. 07, 2013
Applicant:

Grifols Therapeutics Inc., Research Triangle Park, NC (US);

Inventors:

Thomas P Zimmerman, Raleigh, NC (US);

Valery Novokhatny, Raleigh, NC (US);

Shan Jiang, Sammamish, WA (US);

James D Colandene, North Potomac, MD (US);

Assignee:

Grifols Therapeutics Inc., Research Triangle Park, NC (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/48 (2006.01); A61K 38/43 (2006.01); C12N 9/68 (2006.01); A61K 45/06 (2006.01); C12N 9/99 (2006.01); C12N 9/96 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61K 47/18 (2017.01); A61K 47/26 (2006.01);
U.S. Cl.
CPC ...
C12N 9/6435 (2013.01); A61K 38/484 (2013.01); A61K 38/4833 (2013.01); A61K 45/06 (2013.01); C12N 9/96 (2013.01); C12N 9/99 (2013.01); C12Y 304/21007 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/183 (2013.01); A61K 47/26 (2013.01);
Abstract

The present invention provides a fibrinolytic composition useful as a therapeutic for administration to a patient having a thrombotic occlusion. In one aspect of the present invention, the fibrinolytic composition comprises a reversibly inactivated acidified serine protease substantially free of a plasminogen activator, a low buffering capacity buffer, and optionally, a stabilizing agent. In another aspect of the invention, the fibrinolytic composition of the present invention comprises a reversibly inactivated acidified plasmin substantially free of a plasminogen activator, a low buffering capacity buffer, and optionally, a stabilizing agent.


Find Patent Forward Citations

Loading…